| ［1］ |
中华医学会皮肤性病学分会免疫学组, 特应性皮炎协作研究中心. 中国特应性皮炎诊疗指南（2020版）［J］. 中华皮肤科杂志, 2020,53（2）:81⁃88. doi: 10.35541/cjd.20191000.
|
| ［2］ |
中华医学会皮肤性病学分会特应性皮炎研究中心, 中华医学会皮肤性病学分会儿童学组. 度普利尤单抗治疗特应性皮炎专家共识［J］. 中华皮肤科杂志, 2022,55（6）:465⁃470. doi: 10. 35541/cjd.20210885.
|
| ［8］ |
Ferrucci S, Tavecchio S, Veraldi S, et al. Transitory dissemination of molluscum contagiosum in a patient treated with dupilumab for atopic dermatitis［J］. Acta Derm Venereol, 2020,100（14）:adv00207. doi: 10.2340/00015555⁃3565.
|
| ［3］ |
Bitton A, Avlas S, Reichman H, et al. A key role for IL⁃13 signaling via the type 2 IL⁃4 receptor in experimental atopic dermatitis［J］. Sci Immunol, 2020,5（44）:eaaw2938 ［pii］. doi: 10.1126/sciimmunol.aaw2938.
|
| ［4］ |
Di Lernia V, Casanova DM, Simonetti V. Dupilumab kann die abheilung von molluscum contagiosum bei patienten mit atopischer dermatitis erleichtern［J］. J Dtsch Dermatol Ges, 2020,18（9）:1016⁃1018. doi: 10.1111/ddg.14257_g.
|
| ［5］ |
Storan ER, Woolf RT, Smith CH, et al. Clearance of molluscum contagiosum virus infection in patients with atopic eczema treated with dupilumab［J］. Br J Dermatol, 2019,181（2）:385⁃386. doi: 10.1111/bjd.17712.
|
| ［6］ |
Kim BE, Leung D. Significance of skin barrier dysfunction in atopic dermatitis［J］. Allergy Asthma Immunol Res, 2018,10（3）:207⁃215. doi: 10.4168/aair.2018.10.3.207.
|
| ［7］ |
Swiecki M, Colonna M. Disparate antiviral responses in Molluscum contagiosum virus⁃induced skin lesions［J］. J Invest Dermatol, 2011,131（2）:288⁃290. doi: 10.1038/jid.2010.368.
|
| ［8］ |
Fleming P, Drucker AM. Risk of infection in patients with atopic dermatitis treated with dupilumab: a meta⁃analysis of randomized controlled trials［J］. J Am Acad Dermatol, 2018,78（1）:62⁃69. doi: 10.1016/j.jaad.2017.09.052.
|
